Correct Answer: C. Neostigmine
Nicotinic receptor antagonists (non-depolarizing neuromuscular blockers like vecuronium, atracurium, cisatracurium) are used intraoperatively to provide muscle relaxation. Postoperatively, residual neuromuscular blockade must be reversed to restore spontaneous ventilation and airway protection. Neostigmine is an anticholinesterase that inhibits acetylcholinesterase, thereby increasing acetylcholine (ACh) concentration at the neuromuscular junction. This elevated ACh competitively displaces the antagonist from nicotinic receptors, restoring neuromuscular transmission. Neostigmine is the gold standard reversal agent in Indian operating theatres and is given with an antimuscarinic (glycopyrrolate or atropine) to prevent muscarinic side effects (salivation, bronchospasm, bradycardia). The onset is 5–10 minutes, with peak effect at 10–15 minutes. Dosing is 0.04–0.08 mg/kg IV (max 5 mg). Neostigmine is effective only against non-depolarizing blockers; it cannot reverse depolarizing agents like succinylcholine, which requires spontaneous recovery or fresh frozen plasma transfusion in severe cases. Modern practice increasingly uses sugammadex (a selective relaxant binding agent), but neostigmine remains the standard reversal agent in resource-limited Indian settings and is the expected answer in NEET PG.
Why the other options are wrong
A. Carbachol — Carbachol is a non-selective cholinergic agonist (both muscarinic and nicotinic). While it can theoretically increase ACh effects, it is NOT used for neuromuscular blockade reversal because it causes severe muscarinic side effects (bronchospasm, salivation, bradycardia) without the selectivity of anticholinesterases. It is used topically in ophthalmology, not in anesthesia recovery. B. Succinylcholine — Succinylcholine is a depolarizing neuromuscular blocker, not a reversal agent. It causes further muscle paralysis by sustained depolarization. It would worsen, not reverse, neuromuscular blockade. This is a classic NBE trap pairing two neuromuscular drugs to confuse students who conflate all muscle relaxants. D. Physostigmine — Physostigmine is a tertiary amine anticholinesterase that crosses the blood–brain barrier and is used for anticholinergic toxicity (atropine overdose), not neuromuscular blockade reversal. Unlike neostigmine (a quaternary amine), physostigmine causes CNS effects and is contraindicated in operating theatres. It has no role in postoperative recovery from neuromuscular blockade.
High-Yield Facts
- Neostigmine is the standard anticholinesterase for reversing non-depolarizing neuromuscular blockade postoperatively in Indian practice.
- Neostigmine must be given with antimuscarinic (glycopyrrolate 0.01 mg/kg or atropine 0.01 mg/kg) to prevent muscarinic side effects.
- Dose: 0.04–0.08 mg/kg IV (max 5 mg); onset 5–10 min, peak 10–15 min.
- Neostigmine is ineffective against depolarizing blockers (succinylcholine); these require spontaneous recovery or fresh frozen plasma.
- Sugammadex (selective relaxant binding agent) is the modern reversal agent but is expensive and unavailable in most Indian government hospitals; neostigmine remains standard.
Mnemonics
ACHE for Reversal Anticholinesterase (Neostigmine) reverses Competitive (non-depolarizing) blockers by increasing ACh at the neuromuscular junction. Remember: Anticholinesterase = Competitive blocker reversal. Neo-ANTI Rule Neostigmine ALWAYS given with ANTImuscarinic (glycopyrrolate/atropine). Forget the antimuscarinic = salivation, bronchospasm, bradycardia.
NBE Trap
NBE pairs succinylcholine (a depolarizing blocker) with neostigmine (a reversal agent) to trap students who confuse all neuromuscular drugs. The key discriminator: succinylcholine is a depolarizing agent that causes further paralysis, not reversal. Neostigmine works only on non-depolarizing blockers.
Clinical Pearl
In Indian operating theatres, residual neuromuscular blockade is a common cause of postoperative respiratory complications. Neostigmine reversal is routine practice; always ensure the antimuscarinic is drawn up and ready before administering neostigmine to prevent a cholinergic crisis at the bedside.
_Reference: KD Tripathi Pharmacology Ch. 11 (Neuromuscular Blocking Agents); Harrison Ch. 476 (Anesthesia)_